SCHEMBL29610954

SCHEMBL29610954

COc1ccc(CNc2ncnc3c2c(Br)cn3[C@H]2C[C@H](O)[C@@H](CO)O2)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.47
▸ ADK P55263 1/20 0.47
▸ METTL3 Q86U44 1/20 0.45
▸ SLC29A1 Q99808 1/20 0.42
▸ ALDH1A1 P00352 7/20 0.41
▸ CYP1A2 P05177 7/20 0.41
▸ CYP3A4 P08684 7/20 0.41
▸ TSHR P16473 7/20 0.41
▸ CYP2C19 P33261 7/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ CYP2D6 P10635 6/20 0.41
▸ HSD17B10 Q99714 5/20 0.41
▸ CYP2C9 P11712 4/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ USP2 O75604 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ LMNA P02545 3/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313850 1.00 PRMT5 (0.47) PRMT5ADKMETTL3SLC29A1ALDH1A1
SCHEMBL29611468 1.00 PRMT5 (0.47) PRMT5ADKMETTL3SLC29A1ALDH1A1
SCHEMBL27090409 0.86 ADORA1 (0.54) ADKADORA3ADORA2AADORA1
SCHEMBL29611607 0.86 ADORA1 (0.54) ADKADORA3ADORA2AADORA1
SCHEMBL24313840 0.85 METTL3 (0.44) ADKMETTL3SLC29A1ALDH1A1CYP1A2
SCHEMBL29610890 0.85 METTL3 (0.44) ADKMETTL3SLC29A1ALDH1A1CYP1A2
SCHEMBL19582970 0.85 SLC29A1 (0.59) SLC29A1ADORA3ADORA2AADORA1HIF1A
SCHEMBL23273892 0.81 ADORA3 (0.44) ALDH1A1CYP1A2CYP3A4TSHRCYP2C19
SCHEMBL27091934 0.80 CYP1A2 (0.40) PRMT5METTL3ALDH1A1CYP1A2CYP3A4
SCHEMBL27090398 0.80 CYP1A2 (0.40) PRMT5METTL3ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229067-A1 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081739-A1 METTL3 MODULATORS ACCENT THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
Send feedback